242 related articles for article (PubMed ID: 20435681)
1. Imidazopurinones are markers of physiological genomic damage linked to DNA instability and glyoxalase 1-associated tumour multidrug resistance.
Thornalley PJ; Waris S; Fleming T; Santarius T; Larkin SJ; Winklhofer-Roob BM; Stratton MR; Rabbani N
Nucleic Acids Res; 2010 Sep; 38(16):5432-42. PubMed ID: 20435681
[TBL] [Abstract][Full Text] [Related]
2. Protecting the genome: defence against nucleotide glycation and emerging role of glyoxalase I overexpression in multidrug resistance in cancer chemotherapy.
Thornalley PJ
Biochem Soc Trans; 2003 Dec; 31(Pt 6):1372-7. PubMed ID: 14641066
[TBL] [Abstract][Full Text] [Related]
3. Preparation of nucleotide advanced glycation endproducts--imidazopurinone adducts formed by glycation of deoxyguanosine with glyoxal and methylglyoxal.
Fleming T; Rabbani N; Thornalley PJ
Ann N Y Acad Sci; 2008 Apr; 1126():280-2. PubMed ID: 18448831
[TBL] [Abstract][Full Text] [Related]
4. Methylglyoxal-induced dicarbonyl stress in aging and disease: first steps towards glyoxalase 1-based treatments.
Rabbani N; Xue M; Thornalley PJ
Clin Sci (Lond); 2016 Oct; 130(19):1677-96. PubMed ID: 27555612
[TBL] [Abstract][Full Text] [Related]
5. Dicarbonyl proteome and genome damage in metabolic and vascular disease.
Rabbani N; Thornalley PJ
Biochem Soc Trans; 2014 Apr; 42(2):425-32. PubMed ID: 24646255
[TBL] [Abstract][Full Text] [Related]
6. Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics.
Rabbani N; Xue M; Thornalley PJ
Glycoconj J; 2016 Aug; 33(4):513-25. PubMed ID: 27406712
[TBL] [Abstract][Full Text] [Related]
7. Multiple roles of glyoxalase 1-mediated suppression of methylglyoxal glycation in cancer biology-Involvement in tumour suppression, tumour growth, multidrug resistance and target for chemotherapy.
Rabbani N; Xue M; Weickert MO; Thornalley PJ
Semin Cancer Biol; 2018 Apr; 49():83-93. PubMed ID: 28506645
[TBL] [Abstract][Full Text] [Related]
8. Dicarbonyl stress in clinical obesity.
Masania J; Malczewska-Malec M; Razny U; Goralska J; Zdzienicka A; Kiec-Wilk B; Gruca A; Stancel-Mozwillo J; Dembinska-Kiec A; Rabbani N; Thornalley PJ
Glycoconj J; 2016 Aug; 33(4):581-9. PubMed ID: 27338619
[TBL] [Abstract][Full Text] [Related]
9. Glyoxalase in ageing.
Xue M; Rabbani N; Thornalley PJ
Semin Cell Dev Biol; 2011 May; 22(3):293-301. PubMed ID: 21320620
[TBL] [Abstract][Full Text] [Related]
10. Glyoxalase in tumourigenesis and multidrug resistance.
Thornalley PJ; Rabbani N
Semin Cell Dev Biol; 2011 May; 22(3):318-25. PubMed ID: 21315826
[TBL] [Abstract][Full Text] [Related]
11. Identification of adducts formed in the reactions of malonaldehyde-glyoxal and malonaldehyde-methylglyoxal with adenosine and calf thymus DNA.
Pluskota-Karwatka D; Pawłowicz AJ; Bruszyńska M; Greszkiewicz A; Latajka R; Kronberg L
Chem Biodivers; 2010 Apr; 7(4):959-74. PubMed ID: 20397229
[TBL] [Abstract][Full Text] [Related]
12. Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors.
Rabbani N; Thornalley PJ
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269594
[TBL] [Abstract][Full Text] [Related]
13. Protein Glycation in Plants-An Under-Researched Field with Much Still to Discover.
Rabbani N; Al-Motawa M; Thornalley PJ
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486308
[TBL] [Abstract][Full Text] [Related]
14. Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems--role in ageing and disease.
Thornalley PJ
Drug Metabol Drug Interact; 2008; 23(1-2):125-50. PubMed ID: 18533367
[TBL] [Abstract][Full Text] [Related]
15. Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease.
Kuhla B; Lüth HJ; Haferburg D; Boeck K; Arendt T; Münch G
Ann N Y Acad Sci; 2005 Jun; 1043():211-6. PubMed ID: 16037241
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation.
Xue M; Rabbani N; Momiji H; Imbasi P; Anwar MM; Kitteringham N; Park BK; Souma T; Moriguchi T; Yamamoto M; Thornalley PJ
Biochem J; 2012 Apr; 443(1):213-22. PubMed ID: 22188542
[TBL] [Abstract][Full Text] [Related]
17. The dicarbonyl proteome: proteins susceptible to dicarbonyl glycation at functional sites in health, aging, and disease.
Rabbani N; Thornalley PJ
Ann N Y Acad Sci; 2008 Apr; 1126():124-7. PubMed ID: 18448805
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress and glyoxalase I activity mediate dicarbonyl toxicity in MCF-7 mamma carcinoma cells and a tamoxifen resistant derivative.
Nass N; Sel S; Ignatov A; Roessner A; Kalinski T
Biochim Biophys Acta; 2016 Jun; 1860(6):1272-80. PubMed ID: 26971627
[TBL] [Abstract][Full Text] [Related]
19. Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation.
Ruggiero-Lopez D; Lecomte M; Moinet G; Patereau G; Lagarde M; Wiernsperger N
Biochem Pharmacol; 1999 Dec; 58(11):1765-73. PubMed ID: 10571251
[TBL] [Abstract][Full Text] [Related]
20. Glyoxalase System in the Progression of Skin Aging and Skin Malignancies.
Yumnam S; Subedi L; Kim SY
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
